Fidelity Advisor Biotechnology Fund
Filed by Fidelity Advisor Series VII. What this fund reported holding in its latest quarterly NPORT-P. Positions are ordered by share of the fund rather than by size, because that is what separates a conviction from a rounding error.
What it holds
Largest share of the fund first.
| Company | % of fund | Value |
|---|---|---|
| ABBVAbbVie Inc | 14.71% | $323.7M |
| GILDGilead Sciences, Inc | 5.70% | $125.5M |
| ALNYAlnylam Pharmaceuticals Inc | 3.62% | $79.6M |
| COGTCogent Biosciences Inc | 3.25% | $71.4M |
| INSMInsmed Inc | 3.05% | $67.1M |
| ARGXargenx SE | 3.00% | $65.9M |
| BIIBBiogen Inc | 2.71% | $59.7M |
| AMGNAmgen Inc | 2.37% | $52M |
| AMLXAmylyx Pharmaceuticals Inc | 2.25% | $49.4M |
| PCVXVaxcyte Inc | 1.97% | $43.3M |
| MRNAModerna Inc | 1.60% | $35.1M |
| RLAYRelay Therapeutics Inc | 1.58% | $34.8M |
| NTRANatera Inc | 1.43% | $31.4M |
| VRTXVertex Pharmaceuticals Inc | 1.39% | $30.5M |
| GPCRStructure Therapeutics Inc | 1.15% | $25.4M |
| PRAXPraxis Precision Medicines Inc | 1.04% | $22.8M |
| REGNRegeneron Pharmaceuticals Inc | 0.78% | $17.2M |
| MDGLMadrigal Pharmaceuticals Inc | 0.22% | $4.8M |
| BBIOBridgeBio Pharma Inc | 0.17% | $3.8M |
| KODKodiak Sciences Inc | 0.17% | $3.7M |
| TECXTectonic Therapeutic, Inc. - Common Stock | 0.15% | $3.4M |
Source: NPORT-P filings, via EDGAR. Positions arrive by CUSIP, and only a CUSIP verified against a ticker is kept — so this is what we could match, not everything the fund holds, and the matched value is therefore below the fund's own size. A balance is shares where the filing says `NS` and a principal amount where it says `PA`, which is why it is not labelled shares in both cases.
Follow Fidelity Advisor Biotechnology Fund by email
Fidelity Advisor Biotechnology Fund's new holdings reports, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.